Eguono Maples, APRN

Eguono Maples practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Eguono Maples' NPI, 1568874220, was assigned on May 28, 2014. Eguono Maples holds Texas license 1089698.

Eguono Maples' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Eguono Maples' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Eguono Maples practices. Vendor and product names are available with a free account.

Acute care is Eguono Maples' primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Eguono Maples is licensed in Texas.

CMS counts 105 Medicare patients who saw Eguono Maples in 2024. The largest group is 65 to 74, with 49 patients. 71% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eguono Maples' median patient age at 71, with 47% women.

In 2024, Eguono Maples wrote 400 Medicare Part D claims for 63 patients. 92% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Eguono Maples for performance year 2024, reported as part of a group. Eguono Maples accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Eguono Maples as offering telehealth.

CMS Open Payments shows 6 general payments to Eguono Maples from 4 drug and device companies in 2025. Food and beverage make up the largest share, 68% of the total. Incyte Corporation paid the most, $130.